# Who does Cardinal Health, Inc. pay? Who are its key suppliers?
Canonical: https://valuechain.wiki/cardinal-health · Facet: suppliers · Updated: 2026-09-23T09:58:34.815097+00:00 · Source: ValueChain.wiki (cited money-flow graph)

**Citable summary**: Cardinal Health, Inc.'s confirmed suppliers/cost counterparties include Amgen, Bristol-Myers Squibb Company, Moderna plus 6 undisclosed/aggregate relationships. Per the valuechain.wiki graph: 9 cost edges, backed by 10 dated sources, 8 of them primary filings (as of 2026-09-23).

### 암젠 (high)  → /amgen.md
- metric: Amount $12.6B · FY2025 · Amgen-reported gross product sales to Cardinal Health
- note: Amgen uses Cardinal Health as a major pharmaceutical wholesale customer. Amgen reported $12.562 billion of FY2025 gross product sales to Cardinal Health, evidencing Cardinal Health's sourcing relationship from the manufacturer side.
- [confirms] SEC EDGAR (EN, filing, published 2026-02-13) https://www.sec.gov/Archives/edgar/data/318154/000031815426000010/amgn-20251231.htm: "Cardinal Health, Inc.: Gross product sales $12,562 million."

### Solaris Health (high)
- metric: Amount $1.9B · Acquisition completed 2025-11-03 · Cash purchase price for Solaris Health
- note: Cardinal Health completed its acquisition of urology management-services organization Solaris Health in November 2025. The cash purchase price was approximately $1.9 billion, and the business joined the multi-specialty platform The Specialty Alliance.
- [confirms] SEC EDGAR (EN, filing, published 2026-08-11) https://www.sec.gov/Archives/edgar/data/721371/000072137126000038/cah-20260630.htm: "$1.9 billion in cash"
- [mentions] Investing.com Korea (KO, news, published 2025-08-12) https://kr.investing.com/news/earnings/article-1590845: "Cardinal Health announced the acquisition of Solaris Health, which has more than 750 providers."

### 브리스톨 마이어스 스퀴브 (high)  → /bristol-myers-squibb.md
- note: Cardinal Health is one of BMS's three largest U.S. pharmaceutical wholesale customers, with gross revenue to Cardinal Health representing 22% of BMS's U.S. gross revenue in 2025.
- [confirms] SEC EDGAR (EN, filing, published 2026-02-11) https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/bmy-20251231.htm: "Cardinal Health, Inc. | 22% | 22% | 23%."

### 모더나 (high)  → /moderna.md
- note: Cardinal Health was a U.S. distribution customer representing 11% of Moderna's FY2025 total revenue, while the absolute revenue amount by counterparty was not disclosed.
- [confirms] SEC EDGAR (EN, filing, published 2026-02-20) https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/mrna-20251231.htm: "Cardinal Health | 11 | %."

### 애브비 (high)  → /abbvie.md
- note: AbbVie sells its U.S. pharmaceutical products through major wholesalers including Cardinal Health. AbbVie does not disclose the amount or share attributable specifically to Cardinal Health.
- [confirms] SEC EDGAR (EN, filing, published 2026-02-20) https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/abbv-20251231.htm: "three wholesale distributors (McKesson Corporation, Cardinal Health, Inc. and Cencora, Inc.)"

### 길리어드 사이언스 (high)  → /gilead-sciences.md
- note: Cardinal Health and its specialty distributor affiliates are major U.S. wholesale customers of Gilead and represented 29% of Gilead's total gross product sales in FY2025.
- [confirms] SEC EDGAR (EN, filing, published 2026-02-24) https://www.sec.gov/Archives/edgar/data/882095/000088209526000006/gild-20251231.htm: "Cardinal Health, Inc. 29%."

### 화이자 (high)  → /pfizer.md
- note: Cardinal Health is Pfizer's third-largest U.S. wholesaler customer and represented a double-digit share of FY2025 total revenue.
- [confirms] SEC EDGAR (EN, filing, published 2026-02-26) https://www.sec.gov/Archives/edgar/data/78003/000007800326000026/pfe-20251231.htm: "Cardinal Health, Inc. 13%."

### 일라이 릴리 (high)  → /lilly-eli.md
- note: Cardinal Health is one of the three major U.S. wholesalers that buy and distribute Lilly products, and Lilly's 10-K discloses that McKesson, Cencora, and Cardinal each account for 10%+ of consolidated revenue, with Lilly selling to these wholesalers rather than pharmacies and the resulting concentration creating both channel bargaining power and the layer where the gross-to-net gap (rebates, PBMs) forms.
- [confirms] SEC EDGAR (EN, filing, published 2026-02-12) https://www.sec.gov/Archives/edgar/data/59478/000005947826000013/lly-20251231.htm: "Three U.S. wholesalers (McKesson, Cencora, Cardinal) each 10%+ of consolidated revenue"

### 덱스콤 (high)  → /dexcom.md
- note: Cardinal Health, together with two affiliated channels, forms part of Dexcom's U.S. retail and durable-medical-equipment distribution network and remains on its 2026 authorized-distributor list after Dexcom disclosed that the relationship generated at least 10% of FY2022 revenue.
- [confirms] Dexcom (EN, ir, published 2026-09-23) https://www.dexcom.com/en-us/dexcom-suppliers: "Cardinal Health | Retail."
- [confirms] SEC EDGAR (EN, filing, published 2023-02-09) https://www.sec.gov/Archives/edgar/data/1093557/000109355723000024/dxcm-20221231.htm: "Cardinal Health and affiliates, our most significant wholesalers and distributors, each generated 10% or more."

### 벡톤 디킨슨 (mid)  → /becton-dickinson.md
- note: Cardinal Health is a major independent U.S. distributor that warehouses BD products and supports order processing and marketing, while BD revenue attributable to Cardinal Health is not disclosed.
- [confirms] U.S. Court of Appeals for the Seventh Circuit via Justia (EN, analysis, published 2022-03-18) https://law.justia.com/cases/federal/appellate-courts/ca7/21-1513/21-1513-2022-03-18.html: "Cardinal and McKesson are two of the largest distributors of the Products."

Reverse side: https://valuechain.wiki/cardinal-health/customers.md · Ripple: https://valuechain.wiki/cardinal-health/ripple.md

---
Full node: https://valuechain.wiki/cardinal-health.md · JSON: https://valuechain.wiki/cardinal-health.json